BMEA CIK: 1840439

Biomea Fusion, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
177
FY22:
118
FY23:
179
FY24:
68.3
FY25:
58.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
9.14
FY22:
11.5
FY23:
20.7
FY24:
11.6
FY25:
0.52
Total assets
Change from FY21 to FY25
millions USD
FY21:
186
FY22:
129
FY23:
200
FY24:
79.9
FY25:
58.6

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
4.64
FY22:
19.1
FY23:
22.9
FY24:
21.7
FY25:
11.1
(negative)
Change from FY21 to FY25
millions USD
FY21:
2.29
FY22:
1.67
FY23:
7.83
FY24:
6.69
FY25:
17.9
(positive)
Change from FY21 to FY25
millions USD
FY21:
179
FY22:
109
FY23:
169
FY24:
51.6
FY25:
29.6
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
186
FY22:
129
FY23:
200
FY24:
79.9
FY25:
58.6

All amounts in millions USD Data source:SEC EDGAR